Managing 'resistance': is adherence a target for treatment?
- PMID: 25036746
- DOI: 10.1097/MNH.0000000000000045
Managing 'resistance': is adherence a target for treatment?
Abstract
Purpose of review: Adherence to preventive measures and prescribed medications is the cornerstone of the successful management of hypertension. The role of adherence is particularly important when treatments are not providing the expected clinical results, for example, in patients with resistant hypertension. The goal of this article is to review the recent observations regarding drug adherence in resistant hypertension.
Recent findings: Today, the role of drug adherence as a potential cause of resistant hypertension is largely underestimated. Most studies suggest that a low adherence to the prescribed medications can affect up to 50% of patients with resistant hypertension.A good adherence to therapy is generally associated with an improved prognosis. Nonetheless, adherence should probably not be a target for treatment per se because data on adherence should always be interpreted in the view of clinical results. In our opinion, the availability of reliable data on drug adherence would be a major help for physicians to manage patients apparently resistant to therapy.
Summary: The actual development of new drugs for hypertension is slow. Thus, focusing on drug adherence to the drugs available is an important way to improve blood pressure control in the population. More emphasis should be put on measuring drug adherence in patients with resistant hypertension to avoid costly investigations and treatments.
Similar articles
-
Assessment of drug compliance in patients with high blood pressure resistant to antihypertensive therapy.EuroIntervention. 2013 May;9 Suppl R:R29-34. doi: 10.4244/EIJV9SRA6. EuroIntervention. 2013. PMID: 23732152 Review.
-
Medication adherence and resistant hypertension.J Hum Hypertens. 2015 Apr;29(4):213-8. doi: 10.1038/jhh.2014.73. Epub 2014 Sep 11. J Hum Hypertens. 2015. PMID: 25209307 Review.
-
Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects.EuroIntervention. 2013 May;9 Suppl R:R7-9. doi: 10.4244/EIJV9SRA1. EuroIntervention. 2013. PMID: 23732159 No abstract available.
-
Summary and Conclusions.High Blood Press Cardiovasc Prev. 2015 Jul;22 Suppl 1:S23. doi: 10.1007/s40292-015-0094-3. High Blood Press Cardiovasc Prev. 2015. PMID: 26149526 No abstract available.
-
A global approach to hypertension.EuroIntervention. 2013 May;9 Suppl R:R16-20. doi: 10.4244/EIJV9SRA4. EuroIntervention. 2013. PMID: 23732150 Review.
Cited by
-
Adherence to Antihypertensive Medication in Treatment-Resistant Hypertension Undergoing Renal Denervation.J Am Heart Assoc. 2016 Feb 12;5(2):e002343. doi: 10.1161/JAHA.115.002343. J Am Heart Assoc. 2016. PMID: 26873693 Free PMC article.
-
Barriers to medication adherence and links to cardiovascular disease risk factor control: the Framingham Heart Study.Intern Med J. 2018 Apr;48(4):414-421. doi: 10.1111/imj.13687. Intern Med J. 2018. PMID: 29193523 Free PMC article.
-
Interventions to Improve Medication Adherence in Hypertensive Patients: Systematic Review and Meta-analysis.Curr Hypertens Rep. 2015 Dec;17(12):94. doi: 10.1007/s11906-015-0606-5. Curr Hypertens Rep. 2015. PMID: 26560139 Free PMC article.
-
Adherence to antihypertensive medication in Russia: a scoping review of studies on levels, determinants and intervention strategies published between 2000 and 2017.Arch Public Health. 2019 Sep 25;77:43. doi: 10.1186/s13690-019-0366-9. eCollection 2019. Arch Public Health. 2019. PMID: 31572607 Free PMC article.
-
Adherence to Antihypertensive Therapy and Its Determinants: A Systematic Review.Cureus. 2024 May 2;16(5):e59532. doi: 10.7759/cureus.59532. eCollection 2024 May. Cureus. 2024. PMID: 38826951 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials